Skip to main content

Advertisement

Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: Comparative outcomes of heart failure among existent classes of anti-diabetic agents: a network meta-analysis of 171,253 participants from 91 randomized controlled trials

Fig. 1

Network plot of treatment comparisons for heart failure. Direct comparison of treatment is linked with a line, the thickness of which represents the number of trials that assess the comparison. SGLT2i sodium-glucoseco-transporter 2 inhibitors, GLP1ra glucagon-like peptide-1 receptor agonists, DPP4i dipeptidyl peptidase 4 inhibitors, TZD thiazolidinediones, MET metformin, SU sulfonylureas, INS insulin, PLA placebo

Back to article page